Adam Stone has served as a member of Solid’s Board of Directors since November 2015.

Mr. Stone is currently the Chief Investment Officer of Perceptive Advisors, a life sciences focused investing firm, where he has worked since 2006. Since July 2021 and February 2021, respectively, Mr. Stone has served as a director and Chief Executive Officer of ARYA Sciences Acquisition Corp V and ARYA Sciences Acquisition Corp IV.

Mr. Stone is currently a member of the Board of Directors of Immatics N.V., a public biopharmaceutical company, and LianBio and Xontogency LLC, both private companies. He previously served as a member of the Board of Directors of Renovia Inc. and Prometheus Biosciences, Inc.

Mr. Stone received a B.A. in molecular biology from Princeton University.